TxCell Company

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Technology: Anti-infective Drugs
Industry: PharmTech
Headquarters: Valbonne, Provence-Alpes-Cote d'Azur, France
Founded Date: 2001-01-01
Employees Number: 51-100
Funding Status: M&A
Investors Number: 1
Total Funding: $6.3M
Estimated Revenue: Less than $1M
Last Funding Type: Debt Financing

Visit Website
Register and Claim Ownership